Amgen is a large-cap healthcare pick for its pipeline, which holds interesting developments, and an upgrade cycle that is starting. x.com 

Moderna, biotech stocks, AbbVie and Amgen have bullish chart setups. Their daily charts are in uptrends, with the latest strong bullish candles confirming momentum alongside steady, strong whale accumulation. x.com 

Amgen's run as a safety trade is near the point where it typically rolls over. Such trades usually work until the stock reaches 16-17x earnings, and Amgen is now close to that level. x.com 

Biotech looks like a sector that wants to trend higher. Biotech M&A drove a heavy-volume weekly move to the top of a multi-month range; it just needs some help from the macro environment. x.com